In celebration of Living Proof week, Insight honors cancer survivors with daily posts about survivorship. The United States today is home to an estimated 12 million cancer survivors, thanks largely to advances in cancer treatment. But the end of treatment is not the end of the cancer experience. For many cancer survivors and caregivers, the years after cancer treatment can bring physical and psychological challenges, says Ann Partridge, MD, MPH, founder and director of Dana-Farber’s Program for Young Women with Breast Cancer and director of the Adult Survivorship Program.
Musician Sheryl Crow announced on June 5 that she has a benign brain tumor known as a meningioma. Below, doctors from Dana-Farber’s Center for Neuro-Oncology describe this condition. The singer-songwriter, a breast cancer survivor, visited Dana-Farber in 2006. Meningiomas are tumors on the surface of the brain, spinal cord, and fluid spaces. They are the most common type of brain tumor, with approximately 55,000 new cases diagnosed annually in the United States.
With the pitter patter of small feet, Phil makes his way through the halls of Boston Children’s Hospital. He walks with a purpose, boarding the elevator that takes him to the oncology floor for his next appointment. Phil is a new face in 6 North, the oncology unit at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center. A spunky pug mix who knows a trick or two, Phil is one of nine therapy dogs who visit pediatric patients at Boston Children’s Hospital as part of the Pawprints Program. What he lacks in medical credentials and size, he easily makes up for in …
When Good Morning America host Robin Roberts revealed that she has myelodysplastic syndrome (MDS), she turned a spotlight on a group of blood disorders that affect an estimated 35,000 to 55,000 people in the United States. In patients with MDS, the bone marrow fails to produce normal quantities of blood cells and the cells themselves are often abnormal, resulting in anemia and an array of symptoms including paleness, fatigue, susceptibility to infections, and easy bruising or bleeding. The syndrome, of which there are at least 15,000 new diagnoses each year in the United States, formerly was known as “pre-leukemia” because about …
Inflammatory breast cancer (IBC) is a rare but aggressive form of breast cancer that affects young women more than older women. Because it’s relatively uncommon — it represents less than five percent of all breast cancer cases — people are often confused about what inflammatory breast cancer is and how you can detect it. As a breast oncologist specializing in inflammatory breast cancer, I want to share some of the common myths to help you separate fact from fiction about IBC.
What’s a cancer scientist doing earning an award for diabetes or cardiovascular research? The two Dana-Farber scientists who received the prizes in early June say they are great examples of how research that isn’t tied to specific goals can lead to unanticipated discoveries in other areas. They argue that just as their unrestricted pursuit of scientific questions in cancer biology has paid off in two different fields of biomedicine – diabetes and heart disease – research that originally wasn’t related to cancer has shed light on the roots of malignant diseases.
Immunotherapy is one of the most technologically advanced yet basic forms of cancer treatment. It uses the body’s own defense mechanism, the immune system, to fight cancer. Immunotherapy is probably most familiar to you in the form of vaccinations for the flu, polio, chicken pox, and other contagious diseases. In those cases, people are injected with a dead or weakened form of the virus responsible for the disease. That prompts the immune system to produce antibodies and white blood cells that ward off infection from the live virus. For cancer prevention, two immune system-stimulating vaccines are now in use: one …
“I don’t believe that optimism can cure cancer, but I do believe one’s general health around the edges can make a difference.” Sam Donaldson, ABC News contributor, learned he had melanoma (a type of skin cancer) in 1997. Despite his diagnosis, he opted to stay positive and learn all he could about his disease. Now chairman of the foundation board at the National Comprehensive Cancer Network (NCCN), Donaldson also works with other cancer research on survivorship initiatives. He talked to us about what he learned, and shares some of his insights here.
It’s not always easy to recognize that we live in a golden age. Too often we fail to appreciate the amazing things going on around us because we‘re so caught up in day-to-day activities and pressing demands that we presume that the extraordinary is rather ordinary. So it may be with cancer treatment in 2012. And the future looks to be even better – not necessarily easier, simpler, or cheaper, but unequivocally better. Here are five reasons why.
Hilary Olson had no reason to suspect that her daughter Hailey might have a brain tumor. “Her smile was starting to droop a little, and one of her eyes was a little jumpy,” says the 6-year-old’s mother. “We took her to see a neurologist, and he thought she might have pinched a nerve. “But when he sent us to Boston Children’s Hospital for an MRI,” she continues, “the radiologists sent us straight down to the emergency room.”